Literature DB >> 14611668

The roles of hepatitis C virus proteins in modulation of cellular functions: a novel action mechanism of the HCV core protein on gene regulation by nuclear hormone receptors.

Koichi Watashi1, Kunitada Shimotohno.   

Abstract

Hepatitis C virus (HCV) is one of the major causative agents inducing the development of hepatocellular carcinoma. The underlying mechanism of HCV pathogenesis, however, is largely un-known. Recent reports have implicated specific HCV proteins in persistent HCV infection, reduction of interferon sensitivity, and the modulation of cell proliferation, including alterations in apoptotic responses. However, the roles of these viral proteins remain controversial, because of conflicting results. Thus, it remains necessary to elucidate the precise molecular mechanisms through which the viral proteins influence cell growth and pathogenesis. In this review, after briefly describing what is known about the roles of the HCV proteins, in particular HCV core protein (core), in the modulation of cellular functions, we propose a novel molecular mechanism of the core in modulating gene expression via activation of nuclear hormone receptors.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14611668     DOI: 10.1111/j.1349-7006.2003.tb01381.x

Source DB:  PubMed          Journal:  Cancer Sci        ISSN: 1347-9032            Impact factor:   6.716


  9 in total

1.  Repression of interferon regulatory factor 1 by hepatitis C virus core protein results in inhibition of antiviral and immunomodulatory genes.

Authors:  Anna R Ciccaglione; Emilia Stellacci; Cinzia Marcantonio; Valentina Muto; Michele Equestre; Giulia Marsili; Maria Rapicetta; Angela Battistini
Journal:  J Virol       Date:  2006-10-18       Impact factor: 5.103

2.  Down-regulation of PTEN by HCV core protein through activating nuclear factor-κB.

Authors:  Yong Zhang; Rong-Qing Li; Xu-Dong Feng; Yan-Hua Zhang; Li Wang
Journal:  Int J Clin Exp Pathol       Date:  2014-10-15

3.  Diverse effects of cyclosporine on hepatitis C virus strain replication.

Authors:  Naoto Ishii; Koichi Watashi; Takayuki Hishiki; Kaku Goto; Daisuke Inoue; Makoto Hijikata; Takaji Wakita; Nobuyuki Kato; Kunitada Shimotohno
Journal:  J Virol       Date:  2006-05       Impact factor: 5.103

4.  Characterization of hepatitis C virus core protein multimerization and membrane envelopment: revelation of a cascade of core-membrane interactions.

Authors:  Li-Shuang Ai; Yu-Wen Lee; Steve S-L Chen
Journal:  J Virol       Date:  2009-07-15       Impact factor: 5.103

5.  Phenotypic and functional alterations of primary human PBMCs induced by HCV non-enveloped capsid-like particles uptake.

Authors:  Polyxeni P Doumba; Elisavet Serti; Maria Boutsikou; Manousos M Konstadoulakis; Urania Georgopoulou; John Koskinas
Journal:  Cell Mol Life Sci       Date:  2013-05-05       Impact factor: 9.261

6.  Identification of protein inhibitor of activated STAT 4, a novel host interacting partner that involved in bovine viral diarrhea virus growth.

Authors:  Xiaowei Gong; Qiwei Chen; Fuying Zheng
Journal:  Virol J       Date:  2020-04-22       Impact factor: 4.099

Review 7.  The ubiquitin-proteasome system in positive-strand RNA virus infection.

Authors:  Alex GoEun Choi; Jerry Wong; David Marchant; Honglin Luo
Journal:  Rev Med Virol       Date:  2012-07-11       Impact factor: 6.989

8.  Requirement of cellular DDX3 for hepatitis C virus replication is unrelated to its interaction with the viral core protein.

Authors:  Allan G N Angus; David Dalrymple; Steeve Boulant; David R McGivern; Reginald F Clayton; Martin J Scott; Richard Adair; Susan Graham; Ania M Owsianka; Paul Targett-Adams; Kui Li; Takaji Wakita; John McLauchlan; Stanley M Lemon; Arvind H Patel
Journal:  J Gen Virol       Date:  2009-09-30       Impact factor: 3.891

9.  Target delivery of small interfering RNAs with vitamin E-coupled nanoparticles for treating hepatitis C.

Authors:  Liang Duan; Yan Yan; Jingyi Liu; Bo Wang; Pu Li; Qin Hu; Weixian Chen
Journal:  Sci Rep       Date:  2016-04-26       Impact factor: 4.379

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.